Kite to launch mid-stage leukemia trial in fourth quarter 2017

CHICAGO (Reuters) - Kite Pharma Inc said on Monday it planned to launch in the fourth quarter of this year a Phase 2 trial of its experimental T-cell therapy in leukemia patients, possibly at a lower dose than is currently being tested.